Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Kornstein

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Archives of Psychiatric Nursing|December 3, 2014
Potential long-term effects of a mind-body intervention for women with major depressive disorder: sustained mental health improvements with a pilot yoga interventionPatricia Anne Kinser, R K Elswick, Susan Kornstein
International Clinical Psychopharmacology|April 3, 2018
Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trialsSusan Kornstein, Cheng-Tao Chang, Carl P Gommoll, et al.
The Journal of Sexual Medicine|July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorderAnita Clayton, Susan Kornstein, Apurva Prakash, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 31, 2021
The Lullaby Project: A Musical Intervention for Pregnant WomenJennifer Hinesley, Sarah Cunningham, Rashel Charles, et al.
Journal of Women'S Health (2002)|February 5, 2008
Burden of premenstrual dysphoric disorder on health-related quality of lifeMin Yang, Gene Wallenstein, Michael Hagan, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 31, 2021
Adverse Childhood Experiences, Maternal/Fetal Attachment, and Maternal Mental HealthJennifer Hinesley, Ananda Amstadter, Aradhana Sood, et al.
Depression and Anxiety|July 11, 2007
Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorderDavid L Dunner, Michael Wilson, Maurizio Fava, et al.
Women'S Health Reports (New Rochelle, N.Y.)|June 2, 2022
Licit Substance Use and Premenstrual Syndrome Symptom Severity in Female College StudentsKathryn Polak, Pamela Nora, Bridget Perry, et al.
International Clinical Psychopharmacology|June 10, 2017
Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT studyKoichiro Watanabe, Michael E Thase, Toshiaki Kikuchi, et al.
International Clinical Psychopharmacology|April 7, 2007
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trialJames Hartford, Susan Kornstein, Michael Liebowitz, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Archives of Psychiatric Nursing|December 3, 2014
Potential long-term effects of a mind-body intervention for women with major depressive disorder: sustained mental health improvements with a pilot yoga interventionPatricia Anne Kinser, R K Elswick, Susan Kornstein
International Clinical Psychopharmacology|April 3, 2018
Vilazodone efficacy in subgroups of patients with major depressive disorder: a post-hoc analysis of four randomized, double-blind, placebo-controlled trialsSusan Kornstein, Cheng-Tao Chang, Carl P Gommoll, et al.
The Journal of Sexual Medicine|July 14, 2007
Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorderAnita Clayton, Susan Kornstein, Apurva Prakash, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 31, 2021
The Lullaby Project: A Musical Intervention for Pregnant WomenJennifer Hinesley, Sarah Cunningham, Rashel Charles, et al.
Journal of Women'S Health (2002)|February 5, 2008
Burden of premenstrual dysphoric disorder on health-related quality of lifeMin Yang, Gene Wallenstein, Michael Hagan, et al.
Women'S Health Reports (New Rochelle, N.Y.)|March 31, 2021
Adverse Childhood Experiences, Maternal/Fetal Attachment, and Maternal Mental HealthJennifer Hinesley, Ananda Amstadter, Aradhana Sood, et al.
Depression and Anxiety|July 11, 2007
Long-term tolerability and effectiveness of duloxetine in the treatment of major depressive disorderDavid L Dunner, Michael Wilson, Maurizio Fava, et al.
Women'S Health Reports (New Rochelle, N.Y.)|June 2, 2022
Licit Substance Use and Premenstrual Syndrome Symptom Severity in Female College StudentsKathryn Polak, Pamela Nora, Bridget Perry, et al.
International Clinical Psychopharmacology|June 10, 2017
Long-term function and psychosocial outcomes with venlafaxine extended release 75-225 mg/day versus placebo in the PREVENT studyKoichiro Watanabe, Michael E Thase, Toshiaki Kikuchi, et al.
International Clinical Psychopharmacology|April 7, 2007
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trialJames Hartford, Susan Kornstein, Michael Liebowitz, et al.
Pageof 2